Tics Clinical Trials Tics RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.
Condition:   TOURETTE SYNDROME Interventions:   Drug: TEV-50717;   Drug: Placebo Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2018 Category: Research Source Type: clinical trials

Seeking Children Ages 10-17 for Modified Behavioral Therapy for Tics
(Source: ADHD Clinical Trials at Partners Healthcare Massachusetts)
Source: ADHD Clinical Trials at Partners Healthcare Massachusetts - November 28, 2017 Category: Psychiatry Source Type: clinical trials